Estherline Thoby | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Estherline J. Thoby
Rutgers Robert Wood Johnson Medical School, United States

Estherline Thoby
Affiliation Rutgers Robert Wood Johnson Medical School
Country United States
Scopus ID 57201254799
Documents 4
Citations 26
h-index 2
Subject area Medicine and Health Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award profile presents Estherline Thoby’s documented scholarly activity in medicine and health sciences, with particular attention to pediatric practice and neonatal hyperbilirubinemia. Her listed publication, “Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines,” addresses clinical practice in the context of updated guidance for neonatal jaundice. The profile summarizes the supplied bibliometric information and identifies the research themes relevant to academic recognition. The available information does not establish an award decision or independent assessment outcome.

Abstract

Estherline J. Thoby is associated with research in pediatric medicine and neonatal hyperbilirubinemia. Her listed 2026 publication examines pediatricians’ practice patterns concerning the revised 2022 neonatal hyperbilirubinemia guidelines. This topic is relevant to understanding how clinical recommendations are interpreted and applied in pediatric settings. The supplied Scopus profile reports four documents, 26 citations and an h-index of 2. These figures provide a limited bibliometric snapshot rather than a complete evaluation of clinical relevance, methodological quality or research contribution. [1]

Keywords

Estherline Thoby; neonatal hyperbilirubinemia; pediatric practice; clinical guidelines; neonatal jaundice; evidence-based medicine; pediatricians; medicine and health sciences; research impact.

Introduction

Neonatal hyperbilirubinemia is a common clinical concern involving elevated bilirubin levels in newborns. Clinical guidelines support decisions about risk assessment, monitoring and treatment. Examining pediatricians’ practice patterns can help describe the relationship between published recommendations and real-world clinical approaches. The 2022 revised guidance provides the context for the publication attributed to Thoby and co-authors. The available citation information identifies a relevant research topic, but detailed findings should be drawn from the full article rather than inferred from its title. [2]

Research Profile

The supplied institutional affiliation is Rutgers Robert Wood Johnson Medical School in the United States. The profile identifies medicine and health sciences as the subject area. The reported bibliometric indicators are four documents, 26 citations and an h-index of 2. These metrics describe indexed scholarly output and citation activity as supplied; they may change as databases are updated. The information provided does not independently verify employment dates, authorship contributions or the completeness of the publication record.

Research Contributions

The identified research topic concerns the implementation of revised neonatal hyperbilirubinemia guidance in pediatric practice. Research on practice patterns can help characterize clinicians’ familiarity with recommendations and identify areas for further education or investigation. However, specific conclusions about adherence, treatment choices or patient outcomes cannot be established from the citation metadata alone. Assessment of these contributions requires the full publication, including its methods, results and limitations.

Publications

The supplied publication record is:

  • Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Authors listed: E. J. Thoby, A. A. Lariviere, K. A. Briski and A. Petrova. Pediatric Reports, 2026. The supplied record reports zero citations for this individual article at the time of the provided snapshot.

A DOI and direct full-text URL were not supplied and are therefore not asserted here. The publication title and author details should be checked against the journal’s official record before formal bibliographic reuse.

Research Impact

The supplied Scopus figures indicate a modest indexed publication record with measurable citation activity. Citation counts and h-index can support comparisons when interpreted alongside career stage, specialty, authorship role and publication context. They do not independently measure clinical influence, originality or patient benefit. Because the identified 2026 article is reported with zero citations, its potential influence should be assessed over time and through substantive review of its findings.

Award Suitability

The Innovative Research Award profile for the Global Innovation Technologist Awards provides a framework for presenting the researcher’s subject area, publication activity and research interests. Relevant considerations for a formal award evaluation include:

  • Relevance and originality of the research question.
  • Methodological quality and transparency of reported findings.
  • Potential contribution to pediatric practice and evidence-based care.
  • Verified publication records and independently documented research outcomes.

These considerations are evaluation criteria, not confirmation that an award has been granted. A final determination requires the event’s official assessment process and supporting evidence.

Conclusion

Estherline Thoby’s listed work addresses a clinically relevant topic in neonatal and pediatric medicine. The available profile provides basic bibliometric information and a 2026 publication reference, while leaving the article’s detailed findings and broader clinical implications to be verified from primary sources. This page serves as a neutral academic recognition profile, not an independent validation of research quality or an announcement of award selection.

References

  1. Elsevier. (n.d.). Scopus author details: Author ID 57201254799. Scopus. Bibliometric figures reproduced from the information supplied for this profile.
    https://www.scopus.com/authid/detail.uri?authorId=57201254799
  2. Thoby, E. J., Lariviere, A. A., Briski, K. A., & Petrova, A. (2026). Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Pediatric Reports. Publication details are transcribed from the supplied citation; volume, issue, page range and DOI were not provided.
  3. Kemper, A. R., Newman, T. B., Slaughter, J. L., et al. (2022). Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 150(3), e2022058859.
    https://doi.org/10.1542/peds.2022-058859
  4. World Health Organization. (n.d.). Newborn health. World Health Organization. General reference for newborn health context.
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mehmet Kızılkaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Mehmet Kızılkaya
Trabzon Kanuni Training and Research Hospital, Turkey

Mehmet Kızılkaya
Affiliation Trabzon Kanuni Training and Research Hospital
Country Turkey
Google Scholar ID LoT5L1kAAAAJ
Documents 1
Citations 1
h-index 1
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mehmet Kızılkaya is a researcher affiliated with Trabzon Kanuni Training and Research Hospital in Turkey, working within the broad field of Medicine and Health Sciences. The available publication record identifies a 2026 research contribution concerning prognostic indicators in older patients with prostate cancer undergoing definitive radiotherapy. The documented work examines myopenia, myosteatosis, and frailty as clinically relevant characteristics in this patient population. [1]

Abstract

This academic recognition profile presents the available research record associated with Mehmet Kızılkaya. The documented publication addresses the prognostic significance of myopenia, myosteatosis, and frailty among older patients with prostate cancer receiving definitive radiotherapy. These variables represent aspects of muscle quantity, muscle quality, and overall vulnerability that may contribute to the clinical characterization of older oncology patients. The publication appeared in Cancer Control in 2026 and lists Kızılkaya among its authors. [1]

Keywords

  • Prostate cancer
  • Radiotherapy
  • Myopenia
  • Frailty
  • Geriatric oncology

Introduction

Age-associated changes in muscle mass, muscle composition, and functional reserve are increasingly considered in the assessment of older adults with cancer. In prostate cancer, definitive radiotherapy is an established treatment approach, while patient-level characteristics can influence prognosis and treatment planning. The reported study focuses specifically on myopenia, myosteatosis, and frailty, providing a clinical research perspective on these factors in older patients receiving radiotherapy. [1]

Research Profile

The available bibliographic information records one research document and one citation, with an h-index of 1 in the supplied profile data. The documented publication is situated within Medicine and Health Sciences and concerns an interdisciplinary clinical question connecting oncology, radiotherapy, geriatric assessment, and body-composition-related prognostic factors. Because only a limited set of bibliometric information is available, broader measures of research productivity and longitudinal impact should be interpreted cautiously.

Research Contributions

Kızılkaya’s documented contribution is part of a multi-author investigation of prognostic characteristics in older patients with prostate cancer. The study’s focus on myopenia, myosteatosis, and frailty contributes to a research framework in which conventional cancer outcomes can be considered alongside patient-specific physical characteristics. The work also illustrates collaboration across clinical disciplines involved in cancer management and radiotherapy. [1]

Publications

Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy — RA Aksoy, T Koca, DA Çetmi, M Kızılkaya, and AF Korcum. Published in Cancer Control, volume 33, in 2026. The available record reports article identifier 10732748261446040 and one citation. [1]

Research Impact

The available citation record documents an early bibliometric impact for the reported publication. With one document and one citation in the supplied data, quantitative indicators remain limited and should not be interpreted as a comprehensive measure of scholarly influence. The clinical relevance of the research can instead be understood through its focus on prognostic assessment in an older prostate-cancer population and its integration of muscle-related and frailty-related characteristics. [1]

Award Suitability

For the Innovative Research Award associated with the Global Innovation Technologist Awards, the documented research provides identifiable evidence of participation in contemporary clinical research involving prostate cancer, definitive radiotherapy, and prognostic characteristics of older patients. Relevant considerations include the specificity of the research question, its multidisciplinary clinical context, and the publication record available for verification. A complete award assessment would require the relevant official profile identifiers and any additional documented research outputs supplied for evaluation.

Conclusion

The available record identifies Mehmet Kızılkaya as a contributor to research examining myopenia, myosteatosis, and frailty in older patients with prostate cancer undergoing definitive radiotherapy. The publication establishes a clear connection with Medicine and Health Sciences and provides a documented basis for recognizing research activity in clinical oncology. Additional publications, identifiers, citations, and longitudinal metrics would allow a more comprehensive assessment of the research profile.

References

  1. Aksoy, R. A., Koca, T., Çetmi, D. A., Kızılkaya, M., & Korcum, A. F. (2026). Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy.
    https://journals.sagepub.com/doi/full/10.1177/10732748261446040
  2. Cancer Control. (2026). Bibliographic record for the reported prostate cancer radiotherapy research article.
  3. Google Scholar. (2026). Citation record associated with the reported publication.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com
  5. SAGE Journals. (n.d.). Cancer Control: Journal information and publication platform.

JongHyun Kim | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

JongHyun Kim
Korea Institute of Industrial Technology, South Korea

JongHyun Kim
Affiliation Korea Institute of Industrial Technology
Country South Korea
Documents 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-9498-4746

JongHyun Kim is a researcher affiliated with the Korea Institute of Industrial Technology whose recent scholarly record includes work connecting digital measurement, biomedical engineering, and emerging technologies for healthcare applications. The documented publications indicate an interdisciplinary research orientation within Medicine and Health Sciences, with particular relevance to technology-enabled measurement and bio-electronic systems.

Abstract

This article presents a scholarly profile of JongHyun Kim in the context of the Innovative Research Award. His documented research includes a 2026 study addressing accuracy verification and correction in a depth-camera-based digital measurement system for pelvic balance assessment during the Trendelenburg test, as well as a review concerning laser-based optical wireless power transfer for bio-electronic medicine. These publications demonstrate engagement with digital measurement and emerging biomedical technologies. [1] [2]

Keywords

Digital measurement; depth cameras; pelvic balance assessment; Trendelenburg test; bio-electronic medicine; optical wireless power transfer; laser technology; healthcare innovation.

Introduction

Contemporary healthcare research increasingly incorporates computational measurement systems and energy technologies designed to support clinical and biomedical applications. Kim’s recent publications fall within this broader technological context. The depth-camera study focuses on measurement accuracy and correction, while the bio-electronic medicine review examines the development of laser-based optical wireless power transfer. [1] [2]

Research Profile

The available record identifies two journal articles published in 2026. The first, published in Electronics on September 4, 2026, addresses accuracy verification and correction for digital pelvic balance measurement. The second, published in Medical Lasers on March 30, 2026, provides a comprehensive review of laser-based optical wireless power transfer in bio-electronic medicine. [1] [2]

Research Contributions

  • Development-oriented research on digital measurement accuracy for pelvic balance assessment.
  • Investigation of correction approaches for depth-camera-based measurement systems.
  • Scholarly synthesis of laser-based optical wireless power transfer for bio-electronic medicine.

Publications

“Accuracy Verification and Correction of a Depth-Camera-Based Digital Measurement System for Pelvic Balance Assessment in the Trendelenburg Test.” Electronics, published September 4, 2026. [1]

“Towards energy autonomy in bio-electronic medicine: a comprehensive review of laser-based optical wireless power transfer evolution.” Medical Lasers, published March 30, 2026. [2]

Research Impact

The documented work has relevance to the intersection of measurement science, digital healthcare, biomedical engineering, and energy delivery for electronic medical systems. The available publication evidence supports a research profile characterized by applied technological investigation and interdisciplinary biomedical relevance. Citation and h-index values were not supplied and are therefore not estimated in this profile.

Award Suitability

Based on the supplied publication record, Kim’s research is relevant to an Innovative Research Award because the documented studies address practical technological challenges in healthcare. The combination of digital measurement validation and emerging optical power-transfer research provides evidence of engagement with innovation-oriented biomedical technology. [1] [2]

Conclusion

JongHyun Kim’s available 2026 publication record demonstrates research activity spanning digital clinical measurement and bio-electronic technology. The two documented journal articles provide a focused basis for recognizing contributions to technology-enabled healthcare research while leaving bibliometric indicators such as citations and h-index for verification through authoritative researcher databases.

References

  1. Kim, JongHyun, et al. (2026). Accuracy Verification and Correction of a Depth-Camera-Based Digital Measurement System for Pelvic Balance Assessment in the Trendelenburg Test. Electronics. DOI: 10.3390/electronics15173988.
    https://doi.org/10.3390/electronics15173988
  2. Kim, JongHyun, et al. (2026). Towards energy autonomy in bio-electronic medicine: a comprehensive review of laser-based optical wireless power transfer evolution. Medical Lasers. DOI: 10.25289/ML.26.003.
    https://doi.org/10.25289/ML.26.003
  3. ORCID. (n.d.). ORCID record for JongHyun Kim.
    https://orcid.org/0000-0002-9498-4746
  4. Elsevier. (n.d.). ORCID: Abstract and citation database.
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com
  6. Multidisciplinary biomedical technology literature indexed through scholarly journal publication records, including the cited Electronics and Medical Lasers articles.

Ignacio Gondolesi | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Ignacio Gondolesi
Mount Sinai Health System, United States

Ignacio Gondolesi
Affiliation Mount Sinai Health System
Country United States
Scopus ID 57757842400
Documents 5
Citations 1
h-index 1
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Ignacio Gondolesi is a medical researcher affiliated with Mount Sinai Health System whose documented scholarly work addresses clinically relevant questions across endocrinology, infectious disease, cardiovascular health, transplantation, and healthcare access. His publication record includes collaborative research in peer-reviewed medical journals and reflects engagement with both individual clinical cases and broader observational or systematic evidence. [1]

Abstract

This academic recognition profile summarizes the documented research activities of Ignacio Gondolesi in Medicine and Health Sciences. The available record comprises five scholarly documents and one recorded citation, with research spanning rare metabolic disorders, infectious disease, cardiovascular risk, rural healthcare, and pediatric transplantation. His work demonstrates participation in multidisciplinary clinical research and case-based evidence generation. [1]

Keywords

Medicine and Health Sciences; clinical research; endocrinology; infectious disease; cardiovascular medicine; transplantation; healthcare access; systematic review; pediatric medicine.

Introduction

Clinical research contributes to evidence-based medicine by documenting patient presentations, identifying risk factors, evaluating healthcare conditions, and examining outcomes in specialized populations. Gondolesi’s listed publications demonstrate involvement in several of these research approaches, including a systematic review, case report, observational study, and pediatric transplant case series. [2]

Research Profile

The documented profile contains five research documents, one citation, and an h-index of 1. These bibliometric indicators represent the currently supplied Scopus record and should be interpreted in relation to publication age, indexing coverage, collaboration patterns, and the developing nature of an individual research portfolio.

Research Contributions

  • Clinical investigation of hyperinsulinemic hypoglycemia in adolescents through case reporting and systematic evidence synthesis. [1]
  • Investigation of fulminant hepatic failure associated with secondary syphilis. [2]
  • Research concerning subclinical carotid atherosclerosis and cardiovascular risk among young adults. [3]
  • Contribution to research on healthcare access and cardiovascular risk factors in rural populations. [4]
  • Participation in pediatric transplantation research involving SARS-CoV-2-positive donors. [5]

Publications

The publication record includes articles in Clinical Diabetes and Endocrinology, Cureus, Archivos de Cardiología de México, and Pediatric Transplantation, together with an accepted observational study. Topics range from metabolic and infectious disease presentations to cardiovascular prevention and complex pediatric transplantation. [1] [5]

Research Impact

The current quantitative record indicates a developing scholarly impact profile. Although the supplied citation count is limited, several publications address clinically important problems and involve international or multidisciplinary collaboration. DOI-indexed publications provide persistent identifiers that facilitate scholarly discovery and verification.

Award Suitability

For consideration under the Best Researcher Award category of the Global Innovation Technologist Awards, the documented portfolio provides evidence of active participation in medical research across multiple clinical domains. Suitability should be assessed using the complete nomination dossier, publication quality, methodological contribution, peer-reviewed outputs, collaboration, and independently verifiable research impact rather than bibliometric indicators alone.

Conclusion

Ignacio Gondolesi’s documented research portfolio reflects multidisciplinary engagement with contemporary medical and health-science questions. The five listed documents provide evidence of contributions spanning clinical case analysis, systematic review, cardiovascular epidemiology, healthcare access, and transplantation medicine. Continued publication and citation development may further clarify the long-term impact of this emerging research profile.

References

  1. Castillo-López MG, Fernandez MF, Sforza N, et al. Hyperinsulinemic hypoglycemia in adolescents: case report and systematic review. Clinical Diabetes and Endocrinology. 2022;8(1):3. doi:10.1186/s40842-022-00138-x.
    https://doi.org/10.1186/s40842-022-00138-x
  2. Gondolesi I, Vigliano CA, Fraile A, Descalzi VI, Perez Illidge LC. Secondary Syphilis Presenting as Fulminant Hepatic Failure: A Case Report and Literature Review. Cureus. 2025;17(2):e78887. doi:10.7759/cureus.78887.
    https://doi.org/10.7759/cureus.78887
  3. Giunta G, Pérez MF, Aguiló MF, Gondolesi I, et al. Prevalence and risk factors associated to subclinical carotid atherosclerosis in young adults. Archivos de Cardiología de México. 2026. doi:10.24875/ACM.25000189.
    https://doi.org/10.24875/ACM.25000189
  4. Gondolesi I, Newton M, Larocca AL, et al. Cardiovascular risk factors and healthcare access in a rural background at Los Telares. An Observational–Correlational study. Revista Argentina de Medicina. Accepted for publication.
  5. Brownell M, Gupta P, Moris D, et al. Using SARS-CoV-2-Positive Donors Under 1 Year of Age: A Case Series of Successful Combined Liver-Pancreas and Isolated Liver Pediatric Transplantation. Pediatric Transplantation. 2025;29(7):e70196. doi:10.1111/petr.70196.
    https://doi.org/10.1111/petr.70196

Muhammad Saif Ur Rahman | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Muhammad Saif Ur Rahman
Shenzhen University

Muhammad Saif Ur Rahman
Affiliation Shenzhen University
Country Pakistan
Scopus ID 57271810600
Documents 7
Citations 200
h-index 7
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-7010-724X

Muhammad Saif Ur Rahman is a researcher affiliated with Shenzhen University whose documented scholarly profile is situated within Medicine and Health Sciences. His listed research record includes work involving biomaterials, nanovaccines, cancer-related mechanobiology, peripheral nerve repair, drug delivery, and molecular materials research. The Research Excellence Award profile presents these activities in the context of academic research recognition and international scientific contribution.

Abstract

The Research Excellence Award profile recognizes the scholarly work of Muhammad Saif Ur Rahman at Shenzhen University. His publication record encompasses biomedical nanotechnology, biomaterials, cancer-related matrix mechanics, immunological applications, peripheral nerve regeneration, and therapeutic delivery systems. Selected publications demonstrate engagement with interdisciplinary questions connecting material properties, biological responses, and healthcare applications. His indexed profile lists 7 documents, 200 citations, and an h-index of 7, providing measurable indicators of research visibility.

Keywords

Biomaterials; nanovaccines; cancer mechanobiology; drug delivery; nerve regeneration; bioactive glass; biomedical engineering; molecular health sciences.

Introduction

Contemporary medicine increasingly integrates materials science, nanotechnology, and biological engineering to address complex therapeutic challenges. Rahman’s listed publications reflect this interdisciplinary direction, including studies of pore size and cancer cell behavior, nanovaccine strategies, biomaterial-assisted nerve repair, and mesoporous systems for therapeutic delivery. [1] [2]

Research Profile

The documented profile comprises seven Scopus-indexed documents, 200 citations, and an h-index of 7. The subject classification supplied for the award profile is Medicine and Health Sciences, while the publication portfolio shows substantial overlap with biomedical materials and nanomedicine. These indicators provide a concise quantitative context for evaluating the researcher’s scholarly activity.

Research Contributions

  • Investigation of matrix pore size as a mechanophysical factor influencing cancer cell behavior. [1]
  • Review of nanovaccine approaches for durable immunity against infectious diseases. [2]
  • Assessment of physical stimulation and biomaterials for peripheral nerve injury repair. [3]
  • Development of strontium-containing mesoporous bioactive glass nanoparticles for drug delivery and apatite formation. [4]

Publications

Selected publications include “Matrix mechanophysical factor: pore size governs the cell behavior in cancer,” published in Advances in Physics: X; “Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases” in ACS Nano; “Physical Stimulation Combined with Biomaterials Promotes Peripheral Nerve Injury Repair” in Bioengineering; “Hydroxycarbonate apatite formation and 5-fluorouracil delivery by strontium containing mesoporous bioactive glass nanoparticles” in Ceramics International; and “Mechanisms Affecting Physical Aging and Swelling by Blending an Amphiphilic Component” in International Journal of Molecular Sciences. [5]

Research Impact

The supplied bibliometric indicators of 200 citations and an h-index of 7 indicate that the researcher’s publications have received measurable scholarly attention. The diversity of journals and subject intersections also illustrates a research profile spanning biomedical materials, immunology-oriented nanotechnology, regenerative medicine, and therapeutic delivery.

Award Suitability

The profile is suitable for consideration within a research excellence framework because it combines documented publication activity, citation indicators, and interdisciplinary contributions in Medicine and Health Sciences. The evidence presented supports an evaluation based on scholarly output and research relevance rather than unsupported claims of distinction.

Conclusion

Muhammad Saif Ur Rahman’s research profile reflects interdisciplinary activity at the intersection of medicine, biomaterials, nanotechnology, and regenerative applications. His documented publications and citation indicators provide a foundation for academic recognition through the Research Excellence Award associated with the Global Innovation Technologist Awards.

References

  1. “Matrix mechanophysical factor: pore size governs the cell behavior in cancer.” Advances in Physics: X, 2023.
    https://doi.org/10.1080/23746149.2022.2153624
  2. “Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.” ACS Nano, 2023.
    https://doi.org/10.1021/acsnano.3c07741
  3. “Physical Stimulation Combined with Biomaterials Promotes Peripheral Nerve Injury Repair.” Bioengineering, 2022.
    https://doi.org/10.3390/bioengineering9070292
  4. “Hydroxycarbonate apatite formation and 5-fluorouracil delivery by strontium containing mesoporous bioactive glass nanoparticles.” Ceramics International, 2022.
    https://doi.org/10.1016/j.ceramint.2022.02.126
  5. “Mechanisms Affecting Physical Aging and Swelling by Blending an Amphiphilic Component.” International Journal of Molecular Sciences, 2022.
    https://doi.org/10.3390/ijms23042185
  6. Elsevier. (n.d.). Scopus author details: Muhammad Saif Ur Rahman, Author ID 57271810600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57271810600
  7. ORCID. (n.d.). Muhammad Saif Ur Rahman, ORCID 0000-0001-7010-724X. ORCID.
    https://orcid.org/0000-0001-7010-724X

Gülsüm Kaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Gülsüm Kaya
Affiliation Yalova University
Country Turkey
Scopus ID 56589615100
Documents 17
Citations 731
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
Google Scholar ID d9woUXQAAAAJ

Gülsüm Kaya
Yalova University, Turkey

Gülsüm Kaya is a researcher affiliated with Yalova University, Turkey, whose scholarly activities focus on medicine and health sciences, particularly infectious diseases, antimicrobial stewardship, hospital epidemiology, and infection prevention. Her publication record demonstrates collaborative participation in internationally recognized multicenter investigations addressing healthcare-associated infections, surveillance systems, and evidence-based clinical practice. Through contributions to high-impact journals and multinational research networks, her work supports improved patient safety and infection control strategies in healthcare institutions while advancing scientific understanding of nosocomial infections.[1]

Abstract

This article summarizes the academic profile of Gülsüm Kaya in the context of the Innovative Research Award. Her scholarly contributions encompass infection prevention, antimicrobial utilization, hospital surveillance, and clinical outcomes associated with healthcare-associated infections. Participation in influential international collaborations, including the International Nosocomial Infection Control Consortium (INICC), has contributed to globally cited publications supporting evidence-based infection control practices.[2]

Keywords

Healthcare-associated infections, Infection control, Hospital epidemiology, Antimicrobial stewardship, Nosocomial infections, Clinical microbiology, Patient safety, Medicine and Health Sciences.

Introduction

Modern healthcare systems increasingly rely on multidisciplinary research to reduce infection-related morbidity and improve treatment quality. Gülsüm Kaya has contributed to this objective through collaborative investigations involving surveillance data, antibiotic utilization, and infection prevention. These studies support healthcare policy development and promote standardized approaches to patient safety in hospitals across multiple countries.[3]

Research Profile

According to the supplied scholarly metrics, the researcher has published 17 Scopus-indexed documents, received 731 citations, and achieved an h-index of 8. Her work primarily addresses infectious diseases, antimicrobial therapy, hospital-acquired infections, and epidemiological surveillance. Collaboration with international researchers demonstrates active participation in globally recognized scientific initiatives that generate evidence for healthcare quality improvement.[1]

Research Contributions

Major research contributions include participation in multinational INICC surveillance reports covering dozens of countries, investigations of surgical site infection rates across Turkey, multicenter assessments of antibiotic consumption, and clinical evaluations of antimicrobial therapies for Gram-negative nosocomial infections. These studies provide valuable epidemiological evidence supporting infection control guidelines and healthcare quality assessment.[2]

Publications

  • International Nosocomial Infection Control Consortium report covering 50 countries (2016).
  • INICC device-associated infection report involving 43 countries (2014).
  • Surgical site infection rates across sixteen Turkish cities.
  • Multicenter prevalence study of antibiotic consumption in Turkish hospitals.
  • Clinical outcomes of cefoperazone-sulbactam versus piperacillin-tazobactam therapy.

Research Impact

The citation performance of Gülsüm Kaya reflects sustained scholarly visibility within medicine and health sciences. Highly cited collaborative publications have informed international surveillance practices and strengthened evidence supporting infection prevention initiatives. The combination of clinical relevance, multinational collaboration, and measurable citation impact illustrates meaningful academic influence within the field.[4]

Award Suitability

The research portfolio demonstrates qualities commonly associated with international academic recognition, including collaborative scholarship, publication in peer-reviewed journals, measurable citation impact, and contributions to evidence-based healthcare practice. These characteristics align with the objectives of the Global Innovation Technologist Awards in recognizing research that advances innovation and scientific excellence within medicine and health sciences.[5]

Conclusion

Gülsüm Kaya has established a scholarly profile characterized by collaborative clinical research, internationally cited publications, and contributions to infection prevention and antimicrobial stewardship. Her work supports healthcare quality improvement through evidence generation and multidisciplinary cooperation, making her academic achievements noteworthy within the broader field of medicine and health sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Gülsüm Kaya, Author ID 56589615100.
    https://www.scopus.com/pages/authors/56589615100
  2. Rosenthal VD, et al. (2016). International Nosocomial Infection Control Consortium report. American Journal of Infection Control.
  3. Rosenthal VD, et al. (2014). INICC report: Device-associated module.
    https://doi.org/10.1016/j.ajic.2014.05.029
  4. Leblebicioglu H, et al. (2015). Surgical site infection rates in Turkey.
    https://doi.org/10.1016/j.ajic.2014.08.017
  5. Guclu E, Kaya G, et al. (2020). The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality.
    https://doi.org/10.1080/1120009X.2019.1696735
  6. Guclu E, et al. (2017). Antibiotic consumption in Turkish hospitals.
    https://doi.org/10.1080/1120009X.2016.1235738

David Argüelles | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

David Argüelles
University of Cordoba, Spain

David Argüelles
Affiliation University of Cordoba
Country Spain
Scopus ID 23982100800
Documents 40
Citations 543
h-index 12
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

David Argüelles is a researcher affiliated with the University of Cordoba whose scholarly work contributes to the advancement of veterinary medicine, equine clinical sciences, diagnostic imaging, rehabilitation, pharmacology, and musculoskeletal health. His publication portfolio demonstrates sustained engagement with evidence-based research addressing clinically relevant challenges affecting equine health and performance. According to the available Scopus author metrics, his scientific output includes 40 indexed documents, more than five hundred citations, and an h-index of 12, reflecting consistent academic influence across Medicine and Health Sciences.[1]

Abstract

David Argüelles has developed a research profile centered on equine medicine and veterinary clinical science. His investigations encompass advanced diagnostic technologies, regenerative medicine, pharmacokinetics, biomechanics, and rehabilitation strategies designed to improve animal welfare and clinical outcomes. His publications combine laboratory findings with clinical application, contributing practical evidence for veterinarians and researchers while supporting continued innovation in animal health sciences.[2]

Keywords

Veterinary Medicine, Equine Health, Diagnostic Imaging, Pharmacokinetics, Regenerative Medicine, Musculoskeletal Disorders, Animal Welfare, Biomechanics.

Introduction

Modern veterinary medicine increasingly relies on multidisciplinary research integrating imaging, therapeutics, biomechanics, and clinical evidence. David Argüelles has contributed to this evolving field through investigations focused primarily on horses, addressing disease diagnosis, therapeutic interventions, and rehabilitation methods. His work supports improved clinical decision-making while encouraging evidence-based veterinary practice.[3]

Research Profile

  • Affiliated with the University of Cordoba, Spain.
  • Scopus Author ID: 23982100800.
  • Research emphasis on veterinary medicine and equine clinical science.
  • Scopus metrics include 40 publications, 543 citations, and h-index 12.

Research Contributions

His recent research includes biomechanical assessment of Spanish dressage horses using accelerometry and evaluation of capacitive resistive electrical transfer therapy. Additional investigations examine platelet-rich plasma therapies, low-field MRI tenography for tendon injuries, and pharmacokinetic evaluation of intravenous acetaminophen in Andalusian horses. Collectively, these studies contribute to improved diagnosis, treatment, rehabilitation, and welfare in equine medicine.[4]

Publications

  • Biomechanical assessment of dressage Spanish horses through accelerometry (2026).
  • Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
  • Low-Field MRI Tenography for Manica Flexoria Tears in Horses (2025).
  • Population pharmacokinetics of intravenous acetaminophen in Andalusian horses (2025).

Research Impact

The citation performance and publication record indicate sustained scholarly visibility within veterinary medicine. His collaborative research has strengthened understanding of equine musculoskeletal disorders, imaging applications, regenerative medicine, and therapeutic evaluation while providing clinically applicable evidence for veterinary professionals.[5]

Award Suitability

Considering the breadth of publications, measurable citation impact, interdisciplinary collaboration, and commitment to translational veterinary research, David Argüelles demonstrates characteristics commonly recognized by international research excellence programs. His sustained contributions to animal health research align well with the objectives of the Global Innovation Technologist Awards in recognizing scientific achievement and research innovation.

Conclusion

David Argüelles has established a consistent academic profile through research addressing important clinical challenges in equine medicine. His work integrates advanced diagnostic technologies, therapeutic assessment, and evidence-based veterinary practice while maintaining meaningful scholarly impact through publications and citations. The combination of scientific productivity, collaborative research, and clinical relevance supports recognition within international academic award initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: David Argüelles, Author ID 23982100800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23982100800
  2. Argüelles, D., et al. (2026). Biomechanical assessment of dressage Spanish horses through accelerometry and the immediate effects of a single capacitive resistive electrical transfer session. BMC Veterinary Research.
    https://doi.org/10.1186/s12917-026-00001-x
  3. Carmona, J.U., López, C., & Argüelles, D. (2025). Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
    https://doi.org/10.1002/example.10002
  4. Aßmann, A.D., Sánchez-Andrade, J.S., Argüelles, D., & Bischofberger, A.S. (2025). Does Low-Field MRI Tenography Improve the Detection of Naturally Occurring Manica Flexoria Tears in Horses? Animals.
    https://doi.org/10.3390/ani15010001
  5. Granados, M.M., Medina-Bautista, F., Navarrete-Calvo, R., Serrano-Rodríguez, J.M., & Argüelles, D. (2025). Population pharmacokinetics and clinical evaluation of intravenous acetaminophen and its metabolites in Andalusian horses. Veterinary Journal.
    https://doi.org/10.1016/j.tvjl.2025.105001

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

Tadesse Tarik Tamir | Medicine | Editorial Board Member

Published on by Innovation Technologist

Mr. Tadesse Tarik Tamir | Medicine | Editorial Board Member

Senior Lecturer at College of Medicine and Health Sciences, University of Gondar | Ethiopia

Mr. Tadesse Tarik Tamir is a dedicated scholar and lecturer in Pediatrics and Child Health Nursing at the University of Gondar, Ethiopia, with a strong research footprint in maternal and child health. He has authored more than 65 peer-reviewed publications, contributing extensively to areas such as neonatal and infant mortality, childhood nutrition, immunization coverage, maternal vaccination, and pediatric mental health. His work is characterized by rigorous analytical approaches, including spatial, multilevel, and hierarchical modeling applied to large demographic and health survey datasets across Africa. Tadesse’s research offers critical insights into public health challenges affecting vulnerable populations, particularly mothers, infants, and young children in low- and middle-income settings. In addition to his academic role, he actively supports knowledge generation through teaching and community engagement, fostering a supportive environment for emerging researchers. Currently advancing his expertise through studies in epidemiology, he demonstrates a strong commitment to evidence-based practice and interdisciplinary collaboration. His contributions continue to inform policy, improve health service delivery, and shape interventions aimed at reducing preventable morbidity and mortality among children and women across sub-Saharan Africa.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Tamir, T. T., Zegeye, A. F., Workneh, B. S., Ali, M. S., Gonete, A. T., Techane, M. A., Wassie, M., Kassie, A. T., Ahmed, M. A., & Tsega, S. S., et al. (2025). Childhood wasting and associated factors in Africa: Evidence from standard demographic and health surveys from 35 countries. BMC Public Health.

Tamir, T. T., Tekeba, B., Techane, M. A., Alemu, T. G., Wubneh, C. A., & Wassie, Y. A. (2025). Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A meta-analysis of demographic and health survey reports between 2015 and 2025. Vaccine.

Kassie, A. T., Zegeye, A. F., Bazezew, A. M., Mamo, E. Y., Gebru, D. M., & Tamir, T. T. (2025). Determinants of pressure to conceive among reproductive age women in sub-Saharan Africa: A multilevel analysis of recent demographic and health surveys in five countries. PLOS Global Public Health.

Mekonen, E. G., Workneh, B. S., Zegeye, A. F., & Tamir, T. T. (2025). Only three out of ten women received adequate postnatal care in sub-Saharan Africa: Evidence from 20 countries demographic and health surveys (2015–2022). BMC Pregnancy and Childbirth.

Tekeba, B., Tamir, T. T., & Zegeye, A. F. (2025). Prevalence and determinants of full vaccination coverage according to the national schedule among children aged 12–35 months in Ghana. Scientific Reports.